COVID-19 Tracker

Case Study: Profiling the host response to COVID-19 infection using the next-generation automated ELISA

From Your Peers: Gaining Deeper Insights into Disease Outcomes—Reaping the Benefits of Fast, Efficient Biomarker Profiling

Researchers are effectively profiling the immune response to COVID-19 infection using Ella, the next-generation automated ELISA. Simple Plex immunoassays help facilitate an understanding between viral load and disease severity.

Download the case study now.

Webinar: New Trends in Virtual Trials

Monday, July 26 | 11am ET / 8am PT 

​Last year, clinical trial platform developer Medable raised $91M in private funding, amid the COVID-19 pandemic that touched off huge demand among pharma companies looking to initiate “siteless” or virtual clinical trials. Explore the role of CROs in siteless trials and the opportunities and challenges for CROs to expand their capabilities in this burgeoning area. Register now.

Webinar: COVID-19 Virus Sequencing for Drug Development

Wednesday, July 28 | 10:30am ET / 7:30am PT

As new COVID-19 variants continue to emerge, virus sequencing will play critical and ongoing role in drug and vaccine development. This webinar will connect insights from population surveillance to potential solutions for drug developers, outline approaches to COVID-19 virus sequencing and more. Register Now.